Complete Genomics Reports New Orders, Flat Q3 Revenues; Sample Prep Issue Delays Q4 Shipments | GenomeWeb

By Julia Karow

Complete Genomics this week posted flat revenues for the third quarter as its order book grew by 3,400 genomes. Due to technical problems associated with an upgrade that temporarily shut down its sample prep facility, the company had to delay the delivery of some genomes planned for the fourth quarter, reducing the total number of genomes it will ship this year by up to 20 percent.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.